Caresyntax Raises $180M to Advance Precision Surgery Platform nextdigitalhealth.com
Caresyntax, a leader in precision surgery, has raised $180m in a series C financing round to advance its precision surgery platform. The funding comprised $100m in growth debt and $80m in equity financing.
Co-founded in 2013 by Dennis Kogan and Bjoern Von Siemens to improve patient outcomes, Caresyntax’s latest funding round was spearheaded by a consortium of companies, including BIONIQ Capital, Surgical. ai, Symbiotic Capital, BlackRock Innovation Capital and MTIP AG.
Report Story
Leave Your Comment